Dr Kathleen Moore emphasizes the need for a more nuanced approach to endometrial cancer treatment, particularly in the ...

Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...

Co-production deals with adalimumab biosimilar manufacturers and PBMs have increased biosimilar adoption, but this ...

Report’ concludes that the whole class of PFAS, except fluoropolymers, is harmful to human health and the environment.

Previous skepticism turns to optimism as the first clinical trials for transplantation with genetically edited pig kidneys ...

Adhering to the recommendations should improve psychological well-being, as well as pelvic, musculoskeletal, and ...

While most guidelines require 6 months of behavioral interventions before prescribing weight-loss drugs, new research shows ...

A rare syndrome linked to purple urine reveals surprising insights into bacterial colonisation, metabolism, and risks for ...

Another long-term casualty of the state/local funding cuts will likely be recruiting, training, and retaining the expert ...

In patients with heart failure, SGLT2 inhibitors after TAVI are associated with major risk reductions in a clinical trial ...

A retrospective review reports that pregnant women with pityriasis rosea onset before 15 weeks have higher rates of ...

Pembrolizumab plus concurrent chemoradiotherapy shows ongoing antitumor activity after about 5 years of follow-up in patients ...